Your browser doesn't support javascript.
loading
Interplay between cognition and weight reduction in individuals following a Mediterranean Diet: Three-year follow-up of the PREDIMED-Plus trial.
Soldevila-Domenech, Natalia; Forcano, Laura; Vintró-Alcaraz, Cristina; Cuenca-Royo, Aida; Pintó, Xavier; Jiménez-Murcia, Susana; García-Gavilán, Jesús F; Nishi, Stephanie K; Babio, Nancy; Gomis-González, Maria; Corella, Dolores; Sorlí, Jose V; Fernandez-Carrión, Rebeca; Martínez-González, Miguel Ángel; Marti, Amelia; Salas-Salvadó, Jordi; Castañer, Olga; Fernández-Aranda, Fernando; Torre, Rafael de la.
Affiliation
  • Soldevila-Domenech N; Integrative Pharmacology and Systems Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003, Barcelona, Spain. Electronic address: nsold
  • Forcano L; Integrative Pharmacology and Systems Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain. Electronic addres
  • Vintró-Alcaraz C; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain; Psychiatry and Mental Health Group, Neuroscience Program, Institut D'Investigació Biomèdica de Bellvitge-ID
  • Cuenca-Royo A; Integrative Pharmacology and Systems Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain. Electronic address: acuenca@imim.es.
  • Pintó X; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Lipid Unit, Department of Internal Medicine, Bellvitge Biomedical Research Institute (IDIBELL)-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, 08908, Barcelona, Spain. Electronic
  • Jiménez-Murcia S; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain; Psychiatry and Mental Health Group, Neuroscience Program, Institut D'Investigació Biomèdica de Bellvitge-ID
  • García-Gavilán JF; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Universitat Rovira I Virgili, Departament de Bioquímica I Biotecnologia, Unitat de Nutrició Humana, Reus, Spain; Institut D'Investigació Sanitària Pere Virgili (IISPV). Hospital Universitari Sa
  • Nishi SK; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Universitat Rovira I Virgili, Departament de Bioquímica I Biotecnologia, Unitat de Nutrició Humana, Reus, Spain; Institut D'Investigació Sanitària Pere Virgili (IISPV). Hospital Universitari Sa
  • Babio N; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Universitat Rovira I Virgili, Departament de Bioquímica I Biotecnologia, Unitat de Nutrició Humana, Reus, Spain; Institut D'Investigació Sanitària Pere Virgili (IISPV). Hospital Universitari Sa
  • Gomis-González M; Integrative Pharmacology and Systems Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain. Electronic address: mgomis@imim.es.
  • Corella D; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010, Valencia, Spain. Electronic address: dolores.corella@uv.es.
  • Sorlí JV; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010, Valencia, Spain. Electronic address: jose.sorli@uv.es.
  • Fernandez-Carrión R; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010, Valencia, Spain. Electronic address: rebeca.fernandez@uv.es.
  • Martínez-González MÁ; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; University of Navarra, Department of Preventive Medicine and Public Health, Pamplona, Spain; Navarra's Health Research Institute (IdiSNA), Pamplona, Spain; Department of Nutrition, Harvard T.H.
  • Marti A; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Navarra's Health Research Institute (IdiSNA), Pamplona, Spain; University of Navarra, Department of Nutrition, Food Sciences and Physiology, Pamplona, Spain. Electronic address: amarti@unav.es.
  • Salas-Salvadó J; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Universitat Rovira I Virgili, Departament de Bioquímica I Biotecnologia, Unitat de Nutrició Humana, Reus, Spain; Institut D'Investigació Sanitària Pere Virgili (IISPV). Hospital Universitari Sa
  • Castañer O; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Cardiovascular Risk and Nutrition Research Group, Hospital Del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain; Endocrinology Service. Institut Hospital Del Mar D'Investigacions
  • Fernández-Aranda F; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029, Madrid, Spain; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain; Psychiatry and Mental Health Group, Neuroscience Program, Institut D'Investigació Biomèdica de Bellvitge-ID
  • Torre R; Integrative Pharmacology and Systems Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003, Barcelona, Spain; CIBER Fisiopatología Obes
Clin Nutr ; 40(9): 5221-5237, 2021 09.
Article in En | MEDLINE | ID: mdl-34474192
BACKGROUND & AIMS: Some cognitive profiles might facilitate successful weight loss and its maintenance. Also, weight reductions may result in cognitive benefits. However, little work to date has examined the interactions between cognition and weight changes in the context of interventions with the Mediterranean diet (MedDiet). We studied the within-subject longitudinal relationships between cognition, body mass index (BMI), physical activity (PA), and quality of life (QoL), in older adults following a MedDiet. METHODS: The PREDIMED-Plus is a primary prevention trial testing the effect of a lifestyle intervention program with an energy-restricted MedDiet (er-MedDiet), weight-loss goals and PA promotion on cardiovascular disease. The PREDIMED-Plus-Cognition sub-study included 487 participants (50% women, mean age 65.2 ± 4.7 years), with overweight/obesity, metabolic syndrome and normal cognitive performance at baseline. A comprehensive neurocognitive test battery was administered at baseline and after 1 and 3 years. RESULTS: Baseline higher performance in verbal memory (OR = 1.5; 95%CI 1.0, 2.1), visuoconstructive praxis and attention (OR = 1.5; 95%CI 0.9, 2.3), and inhibition (OR = 1.3; 95%CI 0.9, 1.9) were associated with a higher odd of achieving at least 8% weight loss after 3 years follow-up in participants randomized to the intervention group. There were moderate improvements in specific tests of memory and executive functions during follow-up. Higher adherence to the er-MedDiet was associated with greater improvements in memory. Women exhibited lower rates of change in global cognition, PA and QoL. Moreover, improvements in memory correlated with reductions in BMI after 1 year (ßSTD = -0.14) and with improvements in PA after 3 years (ßSTD = 0.13). Finally, participants who experienced greater improvements in executive functions and global cognition also experienced greater improvements in their QoL. CONCLUSIONS: This study refines the understanding of the determinants and mutual interrelationships between longitudinally-assessed cognitive performance and weight loss, adding further evidence to the cognitive benefits associated with better adherence to a MedDiet. Our results also suggest that weight loss interventions tailored to the cognitive profile and gender of participants are promising avenues for future studies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Weight Loss / Cognition / Metabolic Syndrome / Diet, Mediterranean / Overweight Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male Language: En Journal: Clin Nutr Year: 2021 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Weight Loss / Cognition / Metabolic Syndrome / Diet, Mediterranean / Overweight Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male Language: En Journal: Clin Nutr Year: 2021 Document type: Article Country of publication: United kingdom